RLMD Financial Statements

Balance sheet, income statement, cash flow, and dividends for Relmada Therapeutics Inc (RLMD).


$15.69M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

RLMD Market Cap. (MRY)


RLMD Shares Outstanding (MRY)


RLMD Assets (MRY)


Total Assets

$45.82M

Total Liabilities

$10.30M

Total Investments

$41.05M

RLMD Income (MRY)


Revenue

$0

Net Income

-$79.98M

Operating Expense

$83.89M

RLMD Cash Flow (MRY)


CF Operations

-$51.76M

CF Investing

$51.56M

CF Financing

-$40.34K

RLMD Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RLMD Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$45,817,818 (-53.03%)

$97,552,042 (-36.20%)

$152,905,179 (-31.53%)

$223,325,811 (88.96%)

Assets Current

$45,795,843 (-53.03%)

$97,508,917 (-36.21%)

$152,870,304 (-31.54%)

$223,297,518 (89.12%)

Assets Non-Current

$21,975 (-49.04%)

$43,125 (23.66%)

$34,875 (23.26%)

$28,293 (-74.88%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$35,521,961 (-58.38%)

$85,357,242 (-39.22%)

$140,436,302 (-32.57%)

$208,264,886 (97.25%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$3,857,026 (-5.73%)

$4,091,568 (-24.17%)

$5,395,905 (-87.86%)

$44,443,439 (1681.02%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$41,052,356 (-55.49%)

$92,232,292 (-35.47%)

$142,926,781 (-14.65%)

$167,466,167 (46.14%)

Investments Current

$41,052,356 (-55.49%)

$92,232,292 (-35.47%)

$142,926,781 (-14.65%)

$167,466,167 (46.14%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$512,432 (493.25%)

$86,377 (-47.91%)

Trade & Non-Trade Payables

$4,130,563 (17.81%)

$3,506,009 (-33.37%)

$5,261,936 (-52.99%)

$11,192,502 (34.10%)

Accumulated Retained Earnings (Deficit)

-$640,882,035 (-14.26%)

-$560,902,681 (-21.38%)

-$462,110,935 (-51.48%)

-$305,067,112 (-70.13%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$10,295,857 (-15.57%)

$12,194,800 (-2.20%)

$12,468,877 (-17.21%)

$15,060,925 (19.50%)

Liabilities Current

$10,291,390 (-15.61%)

$12,194,800 (-2.20%)

$12,468,877 (-17.21%)

$15,060,925 (19.50%)

Liabilities Non-Current

$4,467 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

RLMD Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$37,715,524 (-22.86%)

$48,894,945 (2.02%)

$47,926,077 (36.61%)

$35,081,922 (41.08%)

Research & Development Expense

$46,175,512 (-15.75%)

$54,807,348 (-51.64%)

$113,322,999 (25.05%)

$90,621,570 (151.92%)

Operating Expenses

$83,891,036 (-19.10%)

$103,702,293 (-35.69%)

$161,249,076 (28.28%)

$125,703,492 (106.62%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$79,979,354 (19.04%)

-$98,791,746 (37.09%)

-$157,043,823 (-24.88%)

-$125,751,809 (-111.50%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$79,979,354 (19.04%)

-$98,791,746 (37.09%)

-$157,043,823 (-24.88%)

-$125,751,809 (-111.50%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$79,979,354 (19.04%)

-$98,791,746 (37.09%)

-$157,043,823 (-24.88%)

-$125,751,809 (-111.50%)

Weighted Average Shares

$30,163,751 (0.21%)

$30,099,203 (1.59%)

$29,628,664 (68.80%)

$17,552,738 (12.56%)

Weighted Average Shares Diluted

$30,163,751 (0.21%)

$30,099,203 (1.59%)

$29,628,664 (68.80%)

$17,552,738 (12.56%)

Earning Before Interest & Taxes (EBIT)

-$79,979,354 (19.04%)

-$98,791,746 (37.09%)

-$157,043,823 (-24.88%)

-$125,751,809 (-111.50%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$83,891,036 (19.10%)

-$103,702,293 (35.69%)

-$161,249,076 (-28.28%)

-$125,703,492 (-106.62%)

RLMD Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$51,561,597 (2.20%)

$50,453,332 (155.67%)

$19,733,609 (136.46%)

-$54,118,036 (-57.10%)

Net Cash Flow from Financing

-$40,341 (59.03%)

-$98,463 (-100.22%)

$45,020,474 (-76.05%)

$187,939,473 (560.05%)

Net Cash Flow from Operations

-$51,755,798 (-0.19%)

-$51,659,206 (50.23%)

-$103,801,617 (-12.98%)

-$91,873,395 (-230.38%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$234,542 (82.02%)

-$1,304,337 (96.66%)

-$39,047,534 (-193.09%)

$41,948,042 (224.17%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$51,561,597 (2.20%)

$50,453,332 (155.67%)

$19,733,609 (136.46%)

-$54,118,036 (-57.10%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$246,747 (0%)

$0 (0%)

$43,432,319 (-76.56%)

$185,311,412 (802.76%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$30,188,881 (-31.09%)

$43,811,149 (-0.87%)

$44,194,765 (9.14%)

$40,494,476 (94.90%)

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$1,258 (-66.47%)

RLMD Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-147.60% (-58.03%)

-93.40% (-6.14%)

-88.00% (17.99%)

-107.30% (-113.32%)

Return on Average Assets (ROAA)

-124.50% (-46.30%)

-85.10% (-5.85%)

-80.40% (15.46%)

-95.10% (-97.30%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-153.90% (-43.56%)

-107.20% (0.37%)

-107.60% (13.44%)

-124.30% (-128.49%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.2 (84.47%)

-1.26 (-91.79%)

-0.66 (79.09%)

-3.15 (62.61%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.44 (-69.73%)

1.46 (95.19%)

0.75 (-60.55%)

1.9 (-61.56%)

Debt to Equity Ratio (D/E)

0.29 (102.80%)

0.14 (60.67%)

0.09 (23.61%)

0.07 (-39.50%)

Earnings Per Share (EPS)

-2.65 (19.21%)

-3.28 (38.11%)

-5.3 (25.98%)

-7.16 (-87.93%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.72 (0.00%)

-1.72 (51.01%)

-3.5 (33.07%)

-5.23 (-193.55%)

Book Value Per Share (BVPS)

1.18 (-58.46%)

2.84 (-40.17%)

4.74 (-60.05%)

11.87 (75.23%)

Tangible Assets Book Value Per Share (TABVPS)

1.52 (-53.13%)

3.24 (-37.20%)

5.16 (-59.44%)

12.72 (67.87%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (0%)

0 (0%)

-3 (66.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.18 (85.09%)

-1.19 (-200.00%)

-0.4 (86.95%)

-3.05 (64.67%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

4.45 (-44.35%)

8 (-34.78%)

12.26 (-17.31%)

14.83 (58.26%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$51,755,798 (-0.19%)

-$51,659,206 (50.23%)

-$103,801,617 (-12.98%)

-$91,873,395 (-230.38%)

Enterprise Value (EV)

$14,206,796 (-87.95%)

$117,912,101 (88.59%)

$62,521,849 (-83.70%)

$383,520,306 (-25.29%)

Earnings Before Tax (EBT)

-$79,979,354 (19.04%)

-$98,791,746 (37.09%)

-$157,043,823 (-24.88%)

-$125,751,809 (-111.50%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$79,979,354 (19.04%)

-$98,791,746 (37.09%)

-$157,043,823 (-24.89%)

-$125,750,551 (-111.51%)

Invested Capital

$31,669,402 (-61.03%)

$81,265,674 (-39.82%)

$135,040,397 (-17.57%)

$163,821,447 (58.92%)

Working Capital

$35,504,453 (-58.38%)

$85,314,117 (-39.24%)

$140,401,427 (-32.58%)

$208,236,593 (97.44%)

Tangible Asset Value

$45,817,818 (-53.03%)

$97,552,042 (-36.20%)

$152,905,179 (-31.53%)

$223,325,811 (88.96%)

Market Capitalization

$15,690,585 (-87.41%)

$124,610,700 (18.62%)

$105,046,218 (-73.40%)

$394,969,600 (-24.17%)

Average Equity

$54,171,276 (-48.76%)

$105,722,206 (-40.77%)

$178,507,655 (52.26%)

$117,237,916 (-0.89%)

Average Assets

$64,244,741 (-44.65%)

$116,076,391 (-40.60%)

$195,401,820 (47.78%)

$132,224,015 (7.11%)

Invested Capital Average

$51,985,010 (-43.61%)

$92,183,736 (-36.85%)

$145,978,776 (44.32%)

$101,146,386 (-7.44%)

Shares

30,174,202 (0.25%)

30,099,203 (0.00%)

30,099,203 (71.69%)

17,530,830 (7.94%)